December 31, 2025 · Form 4 insider transaction
Saad Mark E sold 31,346 shares of Axsome Therapeutics, Inc. at $165.18 per share, a transaction worth $5.18M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Such transaction was pursuant to a pre-approved 10b5-1 plan.; Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.; Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $165.00 and $166.09.